The utility of the preoperative neutrophil-Tolymphocyte ratio in predicting severe cholecystitis: A retrospective cohort study

BMC Surgery

Volumn 14, Issue 1, 2014, Pages

  Lee, Sang Kuon ^a   Lee, Sang Chul ^a   Park, Jae Woo ^a   Kim, Say June ^a  

^a Daejeon St Mary's Hospital   (South Korea)

Author keywords

Cholecystitis; Length of hospital stay; Neutrophil To lymphocyte ratio; Prognosis

Indexed keywords

BIOLOGICAL MARKER;

ADOLESCENT; ADULT; AGED; BLOOD; CHOLECYSTECTOMY; CHOLECYSTITIS; FEMALE; HUMAN; LENGTH OF STAY; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; NEUTROPHIL; PROGNOSIS; RETROSPECTIVE STUDY; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; CHOLECYSTECTOMY; CHOLECYSTITIS; FEMALE; HUMANS; LENGTH OF STAY; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; NEUTROPHILS; PROGNOSIS; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84964315507     PISSN: None     EISSN: 14712482     Source Type: Journal    
DOI: 10.1186/1471-2482-14-100     Document Type: Article

References (33)

1. Russo MW, Wei JT, Thiny MT, Gangarosa LM, Brown A, Ringel Y, Shaheen NJ, Sandler RS: Digestive and liver diseases statistics, 2004. Gastroenterology 2004, 126(5):1448-1453.
2. Charalel RA, Jeffrey RB, Shin LK: Complicated cholecystitis: The complementary roles of sonography and computed tomography. Ultrasound Q 2011, 27(3):161-170.
3. Ahmad MM, Macon WL: Gangrene of the gallbladder. Am Surg 1983, 49(3):155-158.
4. Wilson AK, Kozol RA, Salwen WA, Manov LJ, Tennenberg SD: Gangrenous cholecystitis in an urban VA hospital. J Surg Res 1994, 56(5):402-404.
5. Bennett GL, Rusinek H, Lisi V, Israel GM, Krinsky GA, Slywotzky CM, Megibow A: CT findings in acute gangrenous cholecystitis. AJR Am J Roentgenol 2002, 178(2):275-281.
6. Morfin E, Ponka JL, Brush BE: Gangrenous cholecystitis. Arch Surg 1968, 96(4):567-573.
7. Kwon HC, Kim SH, Oh SY, Lee S, Lee JH, Choi HJ, Park KJ, Roh MS, Kim SG, Kim HJ, Lee JH: Clinical significance of preoperative neutrophillymphocyte versus platelet-lymphocyte ratio in patients with operable colorectal cancer. Biomarkers: Biochem Indicat Expo Response Susceptibility Chem 2012, 17(3):216-222.
8. Proctor MJ, Morrison DS, Talwar D, Balmer SM, Fletcher CD, O'Reilly DS, Foulis AK, Horgan PG, McMillan DC: A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study. Eur J Cancer 2011, 47(17):2633-2641.
9. Tamhane UU, Aneja S, Montgomery D, Rogers EK, Eagle KA, Gurm HS: Association between admission neutrophil to lymphocyte ratio and outcomes in patients with acute coronary syndrome. Am J Cardiol 2008, 102(6):653-657.
10. Davis B, Castaneda G, Lopez J: Subtotal cholecystectomy versus total cholecystectomy in complicated cholecystitis. Am Surg 2012, 78(7):814-817.
11. Kantola T, Klintrup K, Vayrynen JP, Vornanen J, Bloigu R, Karhu T, Herzig KH, Napankangas J, Makela J, Karttunen TJ, Tuomisto A, Makinen MJ: Stagedependent alterations of the serum cytokine pattern in colorectal carcinoma. Br J Cancer 2012, 107(10):1729-1736.
12. Motomura T, Shirabe K, Mano Y, Muto J, Toshima T, Umemoto Y, Fukuhara T, Uchiyama H, Ikegami T, Yoshizumi T, Soejima Y, Maehara Y: Neutrophillymphocyte ratio reflects hepatocellular carcinoma recurrence after liver transplantation via inflammatory microenvironment. J Hepatol 2013, 58(1):58-64.
13. Ishizuka M, Nagata H, Takagi K, Iwasaki Y, Kubota K: Combination of platelet count and neutrophil to lymphocyte ratio is a useful predictor of postoperative survival in patients with colorectal cancer. Br J Cancer 2013, 109(2):401-407.
14. Grant RL, Tie ML: False negative biliary scintigraphy in gangrenous cholecystitis. Australas Radiol 2002, 46(1):73-75.
15. Derici H, Kara C, Bozdag AD, Nazli O, Tansug T, Akca E: Diagnosis and treatment of gallbladder perforation. World J Gastroenterol: WJG 2006, 12(48):7832-7836.
16. Bingener J, Stefanidis D, Richards ML, Schwesinger WH, Sirinek KR: Early conversion for gangrenous cholecystitis: impact on outcome. Surg Endosc 2005, 19(8):1139-1141.
17. Choi SB, Han HJ, Kim CY, Kim WB, Song TJ, Suh SO, Kim YC, Choi SY: Early laparoscopic cholecystectomy is the appropriate management for acute gangrenous cholecystitis. Am Surg 2011, 77(4):401-406.
18. Falor AE, Zobel M, Kaji A, Neville A, De Virgilio C: Admission variables predictive of gangrenous cholecystitis. Am Surg 2012, 78(10):1075-1078.
19. Tsushimi T, Matsui N, Takemoto Y, Kurazumi H, Oka K, Seyama A, Morita T: Early laparoscopic cholecystectomy for acute gangrenous cholecystitis. Surg Laparosc Endosc Percutan Tech 2007, 17(1):14-18.
20. Murata A, Okamoto K, Matsuda S, Kuwabara K, Ichimiya Y, Matsuda Y, Kubo T, Fujino Y: Multivariate analysis of factors influencing length of hospitalization and medical costs of cholecystectomy for acute cholecystitis in Japan: A national database analysis. Keio J Med 2013, 62(3):83-94.
21. Guthrie GJ, Charles KA, Roxburgh CS, Horgan PG, McMillan DC, Clarke SJ: The systemic inflammation-based neutrophil-lymphocyte ratio: experience in patients with cancer. Crit Rev Oncol Hematol 2013, 88(1):218-230.
22. Carruthers R, Tho LM, Brown J, Kakumanu S, McCartney E, McDonald AC: Systemic inflammatory response is a predictor of outcome in patients undergoing preoperative chemoradiation for locally advanced rectal cancer. Colorectal Dis: Offic J Assoc Coloproctology Great Brit Ireland 2012, 14(10):e701-e707.
23. Cedres S, Torrejon D, Martinez A, Martinez P, Navarro A, Zamora E, Mulet-Margalef N, Felip E: Neutrophil to lymphocyte ratio (NLR) as an indicator of poor prognosis in stage IV non-small cell lung cancer. Clin Translational Oncol: Offic Publ Fed Spanish Oncol Soc Nat Canc Inst Mexico 2012, 14(11):864-869.
24. Chua TC, Chong CH, Liauw W, Zhao J, Morris DL: Inflammatory markers in blood and serum tumor markers predict survival in patients with epithelial appendiceal neoplasms undergoing surgical cytoreduction and intraperitoneal chemotherapy. Ann Surg 2012, 256(2):342-349.
25. Kishi Y, Kopetz S, Chun YS, Palavecino M, Abdalla EK, Vauthey JN: Blood neutrophil-To-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy. Ann Surg Oncol 2009, 16(3):614-622.
26. Sharaiha RZ, Halazun KJ, Mirza F, Port JL, Lee PC, Neugut AI, Altorki NK, Abrams JA: Elevated preoperative neutrophil:lymphocyte ratio as a predictor of postoperative disease recurrence in esophageal cancer. Ann Surg Oncol 2011, 18(12):3362-3369.
27. Chiang SF, Hung HY, Tang R, Changchien CR, Chen JS, You YT, Chiang JM, Lin JR: Can neutrophil-To-lymphocyte ratio predict the survival of colorectal cancer patients who have received curative surgery electively? Int J Colorectal Dis 2012, 27(10):1347-1357.
28. Malietzis G, Giacometti M, Askari A, Nachiappan S, Kennedy RH, Faiz OD, Aziz O, Jenkins JT: A preoperative neutrophil to lymphocyte ratio of 3 predicts disease-free survival after curative elective colorectal cancer surgery. Ann Surg 2013, 260(2):287-292.
29. Jeong JH, Lim SM, Yun JY, Rhee GW, Lim JY, Cho JY, Kim YR: Comparison of two inflammation-based prognostic scores in patients with unresectable advanced gastric cancer. Oncology 2012, 83(5):292-299.
30. Keizman D, Ish-Shalom M, Huang P, Eisenberger MA, Pili R, Hammers H, Carducci MA: The association of pre-Treatment neutrophil to lymphocyte ratio with response rate, progression free survival and overall survival of patients treated with sunitinib for metastatic renal cell carcinoma. Eur J Cancer 2012, 48(2):202-208.
31. Wang S, Zhang Z, Fang F, Gao X, Sun W, Liu H: The neutrophil/lymphocyte ratio is an independent prognostic indicator in patients with bone metastasis. Oncol Lett 2011, 2(4):735-740.
32. Fox MS, Wilk PJ, Weissmann HS, Freeman LM, Gliedman ML: Acute acalculous cholecystitis. Surg Gynecol Obstet 1984, 159(1):13-16.
33. Ryu JK, Ryu KH, Kim KH: Clinical features of acute acalculous cholecystitis. J Clin Gastroenterol 2003, 36(2):166-169.